CASI Pharmaceuticals, Inc. - CASI

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.058M
QoQ value delta ($000)
-$3.244M (-75.41%)
Implied price effect (QoQ)
-48.99%
Shares
Total shares
1,252,129
QoQ shares delta
-1,345,159 (-51.79%)
Total shares held by funds (by quarter)

Market chart (CASI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
VR Adviser, LLC 839 987,259 0.04%
Woodline Partners LP 113 133,406 0.0%
RENAISSANCE TECHNOLOGIES LLC 36 43,100 0.0%
TWO SIGMA INVESTMENTS, LP 20 23,787 0.0%
BANK OF AMERICA CORP /DE/ 16 19,935 0.0%
GEODE CAPITAL MANAGEMENT, LLC 15 18,808 0.0%
CITADEL ADVISORS LLC 11 14,045 0.0%
ROYAL BANK OF CANADA 8 9,950 0.0%
JPMORGAN CHASE & CO 0 25 0.0%
WELLS FARGO & COMPANY/MN 0 505 0.0%
MORGAN STANLEY 0 367 0.0%
MAI Capital Management 0 5 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 134 0.0%
SIMPLEX TRADING, LLC 0 133 0.0%
UBS Group AG 0 659 0.0%
Colonial Trust Co / SC 0 11 0.0%